CE-Ventures, the corporate venture capital platform of Crescent Enterprises, has invested $38 million in Freya Biosciences in a Series A funding round. Freya Biosciences is a biotech company specializing in women’s health, particularly in microbial immunotherapies for reproductive health conditions. This funding will support the development of Freya’s lead drug candidate, an investigational vaginal microbial immunotherapeutic targeting infertility in women. The funding will also drive the evolution of Freya’s data science platform, focusing on deep microbiome sequencing and immune biomarker profiling. The investment is part of CE-Ventures’ commitment to exploring innovative fields and its belief in the potential of microbial immunotherapies. Other investors in the funding round include Sofinnova Partners, OMX Ventures, and Angelini Ventures.
$38 Million Funding Boost for Breakthroughs: Freya Biosciences Secures CE-Ventures’ Support
Latest from Blog
Arch Venture Partners secures over $3bn for Fund XIII
TLDR: Arch Venture Partners has raised over $3 billion for Fund XIII. Investors in the fund include Alaska Permanent Fund and Rockefeller Brothers Fund. In a recent development, Arch Venture Partners has
Raising Your First Venture Fund: Tips for Success
TLDR: Samir Kaji, a seasoned venture capital professional, shares a six-point plan for raising a venture fund as a first-time fund manager. Key steps include staying focused on a niche, not worrying
Exploring China’s Quantum Computing Breakthrough and VC Trends
TLDR: ONCO stock surged over 80% in pre-market after Altos Venture acquired a stake Chinese low float stocks like DUO rose over 40% in sympathy with large caps Summary: The article discusses
The Blindspot: Venture Capitalists’ Go-To Tool with Fatal Flaw
TLDR: Nader Al-Naji, founder of Bitclout, was arrested for an alleged crypto scam involving VC giant Andreessen Horowitz as a victim. VCs’ pattern matching led them to invest in Al-Naji despite red
Korean startups seek corporate investors in challenging ecosystem climate
TLDR: Korean startups are seeking corporate investors as funding becomes harder to secure. The government in South Korea has relaxed CVC rules to attract more foreign investment. Korean startups are facing a